Next generation sequencing and its application in deciphering head and neck cancer

Oral Oncology

Volumn 50, Issue 4, 2014, Pages 247-253

  Jessri, Maryam ^a,b   Farah, Camile S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Head and neck cancer; Next generation sequencing; Oral cancer; Personalized cancer therapy; RNA seq

Indexed keywords

DNA; DNA FRAGMENT;

BIOINFORMATICS; CANCER GENETICS; COMPARATIVE STUDY; DNA LIBRARY; DNA SEQUENCE; GENE SEQUENCE; HEAD AND NECK CANCER; HUMAN; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PYROSEQUENCING; REVIEW; RNA SEQUENCE;

HEAD AND NECK CANCER; NEXT GENERATION SEQUENCING; ORAL CANCER; PERSONALIZED CANCER THERAPY; RNA-SEQ;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; SEQUENCE ANALYSIS;

EID: 84895495953     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.12.017     Document Type: Review

References (75)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 4 2009 225 249
2. S. Gupta, W. Kong, Y. Peng, Q. Miao, and W.J. Mackillop Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States Int J Cancer 125 9 2009 2159 2165
3. A.J. Kimple, A.D. Torres, R.Z. Yang, and R.J. Kimple HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratification Sensors 12 4 2012 5159 5169
4. M. Hashibe, P. Brennan, S. Benhamou, X. Castellsague, C. Chen, and M.P. Curado et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the international head and neck cancer epidemiology consortium J Natl Cancer Inst 99 10 2007 777 789
5. C.H. Chung, and M.L. Gillison Human papillomavirus in head and neck cancer: Its role in pathogenesis and clinical implications Clin Cancer Res 15 22 2009 6758 6762
6. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, and W.M. Koch et al. Case-control study of human papillomavirus and oropharyngeal cancer New England J Med 356 19 2007 1944 1956
7. M.L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, and S. Begum et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 6 2008 407 420
8. M.W. Lingen, W. Xiao, A. Schmitt, B. Jiang, R. Pickard, and P. Kreinbrink et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas Oral Oncol 49 1 2013 1 8
9. T.J.H. Siebers, M.A.W. Merkx, P.J. Slootweg, W.J.G. Melchers, P. van Cleef, and P.C.M. Wilde No high-risk HPV detected in SCC of the oral tongue in the absolute absence of tobacco and alcohol - a case study of seven patients Oral Max Surg 12 4 2008 185 188
10. A. Salem Dismissing links between HPV and aggressive tongue cancer in young patients Ann Oncol: Off J Eur Soc Med Oncol/ESMO 21 1 2010 13 17
11. M. Kabeya, R. Furuta, K. Kawabata, S. Takahashi, and Y. Ishikawa Prevalence of human papillomavirus in mobile tongue cancer with particular reference to young patients Cancer Sci 103 2 2012 161 168
12. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, and L. Wu et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 9 2000 709 720
13. R. Herrero, X. Castellsagué, M. Pawlita, J. Lissowska, F. Kee, and P. Balaram et al. Human papillomavirus and oral cancer: The international agency for research on cancer multicenter study J Natl Cancer Inst 95 23 2003 1772 1783
14. X.H. Liang, J. Lewis, R. Foote, D. Smith, and D. Kademani Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo clinic experience J Oral Max Surg 66 9 2008 1875 1880
15. F. Farshadpour, G.J. Hordijk, R. Koole, and P.J. Slootweg Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population Oral Dis 13 2 2007 239 243
16. K.R. Dahlstrom, J.A. Little, M.E. Zafereo, M. Lung, Q. Wei, and E.M. Sturgis Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study Head Neck 30 1 2008 75 84
17. S. Baxi, M. Fury, I. Ganly, S. Rao, and D.G. Pfister Ten years of progress in head and neck cancers JNCCN J Natl Compr Cancer Network 10 7 2012 806 810
18. J.A. Woolgar, and A. Triantafyllou Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis Oral Oncol 45 4-5 2009 361 385
19. C.H. Chung, J.S. Parker, G. Karaca, J. Wu, W.K. Funkhouser, and D. Moore et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell 5 5 2004 489 500
20. T.J. Belbin, B. Singh, I. Barber, N. Socci, B. Wenig, and R. Smith et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays Cancer Res 62 4 2002 1184 1190
21. C.H. Chung, J.S. Parker, K. Ely, J. Carter, Y. Yi, and B.A. Murphy et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-κB Signaling as characteristics of a high-risk head and neck squamous cell carcinoma Cancer Res 66 16 2006 8210 8218
22. F. Sanger, S. Nicklen, and A.R. Coulson DNA sequencing with chain-terminating inhibitors Proc Natl Acad Sci USA 74 12 1977 5463 5467
23. Mardis ER. Next-generation sequencing platforms; 2013. p. 287-03.
24. D. Ulahannan, M.B. Kovac, P.J. Mulholland, J.B. Cazier, and I. Tomlinson Technical and implementation issues in using next-generation sequencing of cancers in clinical practice Br J Cancer 109 4 2013 827 835
25. E.E. Schadt, S. Turner, and A. Kasarskis A window into third-generation sequencing Hum Mol Genet 19 R2 2010 R227-R40
26. Mardis ER. Next-generation DNA sequencing methods; 2008. p. 387-402.
27. M. Margulies, M. Egholm, W.E. Altman, S. Attiya, J.S. Bader, and L.A. Bemben et al. Genome sequencing in microfabricated high-density picolitre reactors Nature 437 7057 2005 376 380
28. J.S. Ross, and M. Cronin Whole cancer genome sequencing by next-generation methods Am J Clin Pathol 136 4 2011 527 539
29. L. Ding, M.C. Wendl, D.C. Koboldt, and E.R. Mardis Analysis of next-generation genomic data in cancer: Accomplishments and challenges Hum Mol Genet 19 R2 2010 R188-R96
30. P.J. Campbell, P.J. Stephens, E.D. Pleasance, S. O'Meara, H. Li, and T. Santarius et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing Nat Genet 40 6 2008 722 729
31. K. Wang, J. Kan, S.T. Yuen, S.T. Shi, K.M. Chu, and S. Law et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat Genet 43 12 2011 1219 1223
32. J.M. Rothberg, W. Hinz, T.M. Rearick, J. Schultz, W. Mileski, and M. Davey et al. An integrated semiconductor device enabling non-optical genome sequencing Nature 475 7356 2011 348 352
33. N. Rusk Torrents of sequence Nat. Methods 8 1 2011 44
34. J.F. Boland, C.C. Chung, D. Roberson, J. Mitchell, X. Zhang, and K.M. Im et al. The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing Human Genetics 2013 1 11
35. M. Morey, A. Fernández-Marmiesse, D. Castiñeiras, J.M. Fraga, M.L. Couce, and J.A. Cocho A glimpse into past, present, and future DNA sequencing Mol Genet Metab 110 1-2 2013 3 24
36. M. Foquet, K.T. Samiee, X. Kong, B.P. Chauduri, P.M. Lundquist, and S.W. Turner et al. Improved fabrication of zero-mode waveguides for single-molecule detection J Appl Phys 103 3 2008
37. J. Eid, A. Fehr, J. Gray, K. Luong, J. Lyle, and G. Otto et al. Real-time DNA sequencing from single polymerase molecules Science 323 5910 2009 133 138
38. C. Meldrum, M.A. Doyle, and R.W. Tothill Next-generation sequencing for cancer diagnostics: a practical perspective Clin Biochem Rev 32 4 2011 177 195
39. O. Harismendy, P.C. Ng, R.L. Strausberg, X. Wang, T.B. Stockwell, and K.Y. Beeson et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies Genome Biol 10 3 2009
40. J.C. Dohm, C. Lottaz, T. Borodina, and H. Himmelbauer Substantial biases in ultra-short read data sets from high-throughput DNA sequencing Nucl Acid Res 36 16 2008
41. M.A. Quail, M. Smith, P. Coupland, T.D. Otto, S.R. Harris, and T.R. Connor et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers BMC Genomics 13 1 2012
42. N. Stransky, A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, and A. Sivachenko et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 6046 2011 1157 1160
43. Mroz EA, Rocco JW. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. Oral Oncol; 2012.
44. N. Agrawal, M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, and R.J. Li et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 6046 2011 1154 1157
45. M. Lechner, G.M. Frampton, T. Fenton, A. Feber, G. Palmer, and A. Jay et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors Genome Med 5 5 2013
46. A.C. Nichols, J. Yoo, D.A. Palma, K. Fung, J.H. Franklin, and J. Koropatnick et al. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines Arch Otolaryngol Head Neck Surg 138 8 2012 732 739
47. T.I. Zack, S.E. Schumacher, S.L. Carter, A.D. Cherniack, G. Saksena, and B. Tabak et al. Pan-cancer patterns of somatic copy number alteration Nat Genet 45 10 2013 Sep 26 1134 1140
48. G. Ciriello, M.L. Miller, B.A. Aksoy, Y. Senbabaoglu, N. Schultz, and C. Sander Emerging landscape of oncogenic signatures across human cancers Nat Genet 45 10 2013 Sep 26 1127 1133
49. Scheckenbach K, Baldus SE, Balz V, Freund M, Pakropa P, Sproll C, et al. RAD51C - A new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral Oncology (0); 2013.
50. E. Wawryk-Gawda, P. ChylińskaWrzos, M. LisSochocka, K. Chłapek, K. Bulak, and M. Jedrych et al. P53 protein in proliferation repair and apoptosis of cells Protoplasma 2013 1 9
51. D.M. Shin, N. Charuruks, S.M. Lippman, J.J. Lee, J.Y. Ro, and W.K. Hong et al. P53 protein accumulation and genomic instability in head and neck multistep tumorigenesis Cancer Epidemiol Biomark Prev 10 6 2001 603 609
52. J.O. Boyle, J. Hakim, W. Koch, P. Van Der Riet, R.H. Hruban, and R.A. Roa et al. The incidence of p53 mutations increases with progression of head and neck cancer Cancer Res 53 19 1993 4477 4480
53. S. Arora, P. Aggarwal, A. Pathak, R. Bhandari, F. Duffoo, and S.C. Gulati Molecular genetics of head and neck cancer (Review) Mol Med Rep 6 1 2012 19 22
54. Y.A. Valentin-Vega, J.A. Barboza, G.P. Chau, A.K. El-Naggar, and G. Lozano High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas Hum Pathol 38 10 2007 1553 1562
55. R.D. Farhadieh, A. Salardini, C.G. Gordon Rees, P.J. Russell, J.L. Yang, and R. Smee Protein expression of epidermal growth factor receptor in laryngeal squamous cell carcinoma index tumors correlates with diagnosis of second primary tumors of the upper aero-digestive tract Ann Surg Oncol 16 10 2009 2888 2894
56. H.M. Khandwala, I.E. McCutcheon, A. Flyvbjerg, and K.E. Friend The effects of insulin-like growth factors on tumorigenesis and neoplastic growth Endocr Rev 21 3 2000 215 244
57. M. Resnicoff, D. Abraham, W. Yutanawiboonchai, H.L. Rotman, J. Kajstura, and R. Rubin et al. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo Cancer Res 55 11 1995 2463 2469
58. H. Zeng, K. Datta, M. Neid, J. Li, S. Parangi, and D. Mukhopadhyay Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line Biochem Biophys Res Commun 302 1 2003 46 55
59. A. Chakravarti, J.S. Loeffler, and N.J. Dyson Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling Cancer Res 62 1 2002 200 207
60. N. Peled, M.W. Wynes, N. Ikeda, T. Ohira, K. Yoshida, and J. Qian et al. Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer Cell Oncol 36 4 2013 277 288
61. J.R. Grandis, A. Chakraborty, Q. Zeng, M.F. Melhem, and D.J. Tweardy Downmodulation of TGF-α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells J Cell Biochem 69 1 1998 55 62
62. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
63. S.P. Gao, K.G. Mark, K. Leslie, W. Pao, N. Motoi, and W.L. Gerald et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas J Clin Invest 117 12 2007 3846 3856 PubMed PMID: 18060032. Pubmed Central PMCID: PMC2096430. Epub 2007/12/07. eng
64. W. Pao, and V.A. Miller Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions J Clin Oncol Off J Am Soc Clin Oncol 23 11 2005 2556 2568
65. J.E. Darnell Jr STATs and gene regulation Science 277 5332 1997 1630 1635
66. S. Giraud, F. Bienvenu, S. Avril, H. Gascan, D.M. Heery, and O. Coqueret Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a J Biol Chem 277 10 2002 8004 8011
67. S. Kamakura, K. Oishi, T. Yoshimatsu, M. Nakafuku, N. Masuyama, and Y. Gotoh Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling Nat Cell Biol 6 6 2004 547 554
68. G.P. Dotto Notch tumor suppressor function Oncogene 27 38 2008 5115 5123
69. A.A. Molinolo, P. Amornphimoltham, C.H. Squarize, R.M. Castilho, V. Patel, and J.S. Gutkind Dysregulated molecular networks in head and neck carcinogenesis Oral Oncol 45 4-5 2009 324 334
70. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
71. M.R. Stratton, P.J. Campbell, and P.A. Futreal The cancer genome Nature 458 7239 2009 719 724
72. A.S. Gargis, L. Kalman, M.W. Berry, D.P. Bick, D.P. Dimmock, and T. Hambuch et al. Assuring the quality of next-generation sequencing in clinical laboratory practice Nat Biotechnol 30 11 2012 1033 1036
73. Cancer Genome Atlas Research N, Genome Characterization C, K. Chang, C.J. Creighton, C. Davis, and L. Donehower et al. The cancer genome atlas pan-cancer analysis project Nat Genet 45 10 2013 1113 1120 PubMed PMID: 24071849. Epub 2013/09/28. eng.
74. G. Eng, A. Chen, T. Vess, and G.S. Ginsburg Genome technologies and personalized dental medicine Oral Dis 18 3 2012 223 235
75. C.S. Farah, N. Bhatia, K. John, and B.W. Lee Minimum intervention dentistry in oral medicine Aust Dent J 58 2013 85 94 (Suppl. 1)